Quantcast

Latest blindness Stories

2014-09-22 12:28:34

NEW YORK, September 22, 2014 /PRNewswire/ -- Persistence Market Research (http://www.persistencemarketresearch.com) Released New Market Report on "Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020," the global ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1 million in 2020. Browse the full Global Market Study on...

2014-09-22 08:29:12

IOP Levels Stable and Below 14mmHG after one year in another series MIAMI, Sept. 22, 2014 /PRNewswire/ -- InnFocus, Inc. reported today that it shared one year results from 34 patients treated, utilizing the current surgical technique for the InnFocus MicroShunt (TM) glaucoma drainage implant, at the European Society of Cataract and Refractive Surgery (ESCRS) meeting in London. Logo - http://photos.prnewswire.com/prnh/20140922/147504 Professor Dr. Isabelle Riss of Bordeaux, France...

2014-09-19 23:07:01

InventHelp, a leading invention submission firm, is submitting the Braille Microwave to applicable companies for their review. PITTSBURGH, PA (PRWEB) September 19, 2014 "My friend lost her eyesight, and ever since then, she has experienced difficulties in her everyday life, especially in the kitchen," said an inventor from Houston, Texas. "Her blindness made her unable even to operate a microwave oven, which is why I invented this appliance." She developed the BRAILLE...

2014-09-16 08:29:26

Regeneron plans to submit sBLA for this indication by year end TARRYTOWN, N.Y., Sept. 16, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted EYLEA(®) (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). The designation is based on positive results in two Phase 3 trials (VIVID-DME and VISTA-DME), in which...

2014-09-15 04:21:15

Professor Eberhart Zrenner Leads Discussion of Alpha IMS Patient Results One Year Post Implantation at Europe's Largest Ophthalmology Conference LONDON, Sept. 15, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of...

2014-09-10 08:31:41

Earlier this year upon CFDA approval to the IOPtiMate[TM] system, a strategic distribution agreement was signed with a target of at least 100 systems in China - the world's largest glaucoma markets TEL AVIV, Israel, September 10, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (TASE: BOLT, OTCQX:BLGTY), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate(TM)...

2014-09-10 08:31:11

Shirato Eye Clinic of Tokyo is first Japanese center to use the MicroShunt for Glaucoma MIAMI, Sept. 10, 2014 /PRNewswire/ -- InnFocus, Inc. reported today that the first two surgeries have been conducted in Japan in a clinical investigational study using the InnFocus MicroShunt(TM) glaucoma drainage implant. The surgeries were performed at the Yotsuya Shirato Eye Clinic in Tokyo, Japan. InnFocus has developed a safe, effective, sustainable and easy-to-perform alternative for the...

2014-09-09 12:28:53

WASHINGTON, Sept. 9, 2014 /PRNewswire/ -- In recognition of National Aging Month, the Advanced Medical Technology Association (AdvaMed) has released resources on the benefit and patient value of treatments aimed at three major disease areas specific to the aging population: cataracts, osteoarthritis and diabetes. These resources can be found at http://www.lifechanginginnovation.org/get-facts. Cataracts Key Facts: -- Cataracts affect 24.5 million Americans, and the prevalence of the...

2014-09-08 23:00:44

The advanced stage retinitis pigmentosa patient – considered a trailblazer – now paves the way for her grown children and others also battling the same blinding eye disease Philadelphia, PA (PRWEB) September 08, 2014 A 66 year old blind woman, who recently underwent successful surgery to receive the new FDA-approved “Argus® II” Retinal Prosthesis System in her eye, is already exceeding expectations in her progress to see again with the retinal implant often described as the...

2014-09-08 12:25:35

Dr. Glenn Strauss And Dr. Ajay Singh Discuss New Simulation Technology Offering State-of-the-Art Solution For Eliminating Cataract Blindness NEW YORK, Sept. 8, 2014 /PRNewswire-USNewswire/ -- HelpMeSee Chief Medical Officer, Dr. Glenn Strauss and Dr. Ajay Singh, Assistant Professor of Ophthalmology, University of Kansas School of Medicine, have jointly published a manuscript addressing the burden of global cataract blindness and the urgent need to train surgeons in the Manual Small...


Latest blindness Reference Libraries

0_68c852d52eeb6d2057e521f7d4c6ddc6
2010-09-23 19:56:17

The Braille system is a method that is widely used by blind people to read and write. It was devised in 1821 by Louis Braille, a blind Frenchman. The Braille characters are made up of six dot positions arranged in a rectangle containing two columns of three dots each. Including a subset when dots are not raised, there are sixty-four possible subsets. The positions on the grid are number 1-3 from top to bottom, on the left, and 4-6 from top to bottom on the right. Horizontal Braille text is...

More Articles (1 articles) »
Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related